Nasdaq · Healthcare
FITLIFE BRANDS, INC. (FTLF)
As-reported financials and recent SEC filings for FITLIFE BRANDS, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$81.5M
Net income
$6.3M
Net margin
7.8%
Diluted EPS
$0.63
ROE
14.5%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $81.5M | $64.5M | $52.7M | $28.8M | $27.9M |
| Gross profit | $31.5M | $28.1M | $21.4M | $12.0M | $12.5M |
| Operating income | $10.1M | $13.1M | $7.5M | $5.7M | $6.2M |
| Net income | $6.3M | $9.0M | $5.3M | $4.4M | $5.4M |
| Diluted EPS | $0.63 | $0.91 | $0.54 | $0.00 | $0.55 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
DEFA14A2026-06-26
View on EDGAR →DEFA14A2026-06-26
View on EDGAR →DEF 14A2026-06-26
View on EDGAR →8-K2026-05-22
View on EDGAR →42026-05-19
View on EDGAR →8-K2026-05-14
View on EDGAR →10-Q2026-05-14
View on EDGAR →10-K/A2026-04-21
View on EDGAR →Largest Healthcare peers
Go deeper on FTLF
Search FITLIFE BRANDS, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.